Regeneron Pharmaceuticals, Inc.

REGN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 15, 2026 PRIMARY DOCUMENT
144 Oct 14, 2026
8-K Oct 6, 2026 FORM 8-K
8-K Sep 30, 2026 FORM 8-K
4 Sep 3, 2026 PRIMARY DOCUMENT
4 Sep 3, 2026 PRIMARY DOCUMENT
144 Sep 3, 2026
144 Sep 2, 2026
144 Sep 2, 2026
4 Aug 21, 2026 PRIMARY DOCUMENT
N-PX Aug 20, 2026
4 Aug 20, 2026 PRIMARY DOCUMENT
4 Aug 12, 2026 PRIMARY DOCUMENT
4 Aug 12, 2026 PRIMARY DOCUMENT
144 Aug 10, 2026
144 Aug 10, 2026
13F-HR Aug 7, 2026
10-Q Jul 30, 2026 10-Q
8-K Jul 30, 2026 8-K
4 Jul 7, 2026 PRIMARY DOCUMENT
8-K Jul 6, 2026 FORM 8-K
144 Jul 2, 2026
8-K Jun 17, 2026 FORM 8-K
13F-HR May 8, 2026
4 May 4, 2026 PRIMARY DOCUMENT
← Newer Page 1 of 97 · 2424 filings Older →